Nephrogenic Systemic Fibrosis and Gadolinium: A Perfect Storm
- 1 October 2008
- journal article
- editorial
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 191 (4), 1150-1153
- https://doi.org/10.2214/ajr.08.1327
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic FibrosisAmerican Journal of Roentgenology, 2008
- Validity of the Animal Models for Nephrogenic Systemic FibrosisInvestigative Radiology, 2008
- Gadolinium‐based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: The role of excess ligandJournal of Magnetic Resonance Imaging, 2008
- A Preclinical Study to Investigate the Development of Nephrogenic Systemic Fibrosis: A Possible Role for Gadolinium-Based Contrast MediaInvestigative Radiology, 2008
- Cutaneous changes of nephrogenic systemic fibrosis: Predictor of early mortality and association with gadolinium exposureArthritis & Rheumatism, 2007
- Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be ConcernedAmerican Journal of Roentgenology, 2007
- Gadolinium deposition in nephrogenic fibrosing dermopathyJournal of the American Academy of Dermatology, 2007
- Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosisJournal of the American Academy of Dermatology, 2007
- Nephrogenic Systemic FibrosisJournal of the American Society of Nephrology, 2006
- Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?Nephrology Dialysis Transplantation, 2006